微RNA-1224通过降低瘤中的CBX3表达的调节来抑制细胞增殖
Wei Xia1, Jihe Huang1, Chunhua Sun1
1Department of Orthopedics, Suzhou Wuzhong People's Hospital, Suzhou, Jiangsu 215128, P.R. China.
Oncology letters
|April 22, 2024
概括
微RNA-1224 (miR-1224) 在冠状瘤下调,并通过向染色盒3 (CBX3) 来抑制瘤细胞增殖. 这一发现表明miR-1224作为一种潜在的治疗瘤的目标.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 微RNAs (miRNAs) 涉及各种癌症,影响瘤发育和治疗耐药性.
- 在罕见的骨瘤冠状瘤中,miRNAs的特定作用和机制在很大程度上仍未被探索.
研究的目的:
- 为了研究瘤中microRNAs的表达和功能.
- 阐明miR-1224在瘤细胞增殖中的调节机制,并确定其向基因.
主要方法:
- 分析miRNA序列测序数据从心脏和心脏组织 (GSE56183数据集).
- 在体外评估使用细胞计数套件-8.8的chordoma细胞增殖.
- 生物信息学分析和双光酶记者测定以确定miR-1224和染色盒3 (CBX3) 之间的相互作用.
主要成果:
- 与正常组织相比,miR-1224在瘤组织和细胞系中的表达明显较低.
- 过度表达miR-1224抑制了冠状瘤细胞的增殖,而它的淘汰促进了增殖.
- 鉴定出CBX3是miR-1224的直接标,miR-1224通过降低CBX3的调节来抑制增殖.
结论:
- miR-1224通过向CBX3.3来调节瘤细胞增殖起着至关重要的作用.
- miR-1224/CBX3轴代表了一种潜在的新型治疗瘤治疗标.
相关概念视频
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K


